Style | Citing Format |
---|---|
MLA | Amini MR, et al.. "The Effects of Garcinia Cambogia (Hydroxycitric Acid) on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Phytotherapy Research, vol. 38, no. 2, 2024, pp. 1028-1043. |
APA | Amini MR, Rasaei N, Jalalzadeh M, Akhgarjand C, Hashemian M, Jalali P, Hekmatdoost A (2024). The Effects of Garcinia Cambogia (Hydroxycitric Acid) on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Phytotherapy Research, 38(2), 1028-1043. |
Chicago | Amini MR, Rasaei N, Jalalzadeh M, Akhgarjand C, Hashemian M, Jalali P, Hekmatdoost A. "The Effects of Garcinia Cambogia (Hydroxycitric Acid) on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Phytotherapy Research 38, no. 2 (2024): 1028-1043. |
Harvard | Amini MR et al. (2024) 'The Effects of Garcinia Cambogia (Hydroxycitric Acid) on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Phytotherapy Research, 38(2), pp. 1028-1043. |
Vancouver | Amini MR, Rasaei N, Jalalzadeh M, Akhgarjand C, Hashemian M, Jalali P, et al.. The Effects of Garcinia Cambogia (Hydroxycitric Acid) on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Phytotherapy Research. 2024;38(2):1028-1043. |
BibTex | @article{ author = {Amini MR and Rasaei N and Jalalzadeh M and Akhgarjand C and Hashemian M and Jalali P and Hekmatdoost A}, title = {The Effects of Garcinia Cambogia (Hydroxycitric Acid) on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Trials}, journal = {Phytotherapy Research}, volume = {38}, number = {2}, pages = {1028-1043}, year = {2024} } |
RIS | TY - JOUR AU - Amini MR AU - Rasaei N AU - Jalalzadeh M AU - Akhgarjand C AU - Hashemian M AU - Jalali P AU - Hekmatdoost A TI - The Effects of Garcinia Cambogia (Hydroxycitric Acid) on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Trials JO - Phytotherapy Research VL - 38 IS - 2 SP - 1028 EP - 1043 PY - 2024 ER - |